| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/04/2007 | EP1768978A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 04/04/2007 | EP1768976A1 Crystal forms of (3r)-1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |
| 04/04/2007 | EP1768974A1 Substituted diketopiperazines as oxytocin antagonists |
| 04/04/2007 | EP1768973A1 Substituted quinolones |
| 04/04/2007 | EP1768970A1 Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders |
| 04/04/2007 | EP1768968A1 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 04/04/2007 | EP1768966A1 Coumpounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| 04/04/2007 | EP1768965A1 Method for preparing 5-¬4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3h-¬1,2,4|-triazin-2-yl|benzamide derivatives with p2x7 inhibiting activity by reaction of the derivative unsubstituted in 4-position of the triazine with an oxiran in the presence of a lewis acid |
| 04/04/2007 | EP1768964A1 Quinazoline modulators of hepatocyte growth factor / c-met activity for the treatment of cancer |
| 04/04/2007 | EP1768963A2 Cancer treatment method |
| 04/04/2007 | EP1768961A1 Novel form of celecoxib |
| 04/04/2007 | EP1768960A1 Sulfonamide derivatives |
| 04/04/2007 | EP1768959A2 Hetero isonipecotic modulators of vanilloid vr1 receptor |
| 04/04/2007 | EP1768958A1 New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission |
| 04/04/2007 | EP1768956A1 Amide derivatives as inhibitors of histone deacetylase |
| 04/04/2007 | EP1768955A1 Amide derivatives as inhibitors of histone deacetylase |
| 04/04/2007 | EP1768954A2 2-methylpropanamides and their use as pharmaceuticals |
| 04/04/2007 | EP1768948A1 Substituted amino compounds as 5-ht/na uptake inhibitors |
| 04/04/2007 | EP1768945A1 Substituted hydroxyacetophenon derivatives |
| 04/04/2007 | EP1768748A2 Compositions comprising strontium and vitamin d and uses thereof |
| 04/04/2007 | EP1768718A2 Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders |
| 04/04/2007 | EP1768699A1 Induction of apoptosis in toll-like receptor expressing tumor cells |
| 04/04/2007 | EP1768696A2 Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus |
| 04/04/2007 | EP1768687A2 Methods and compositions related to the modulation of intercellular junctions |
| 04/04/2007 | EP1768679A1 MODULATION OF GSK-3&bgr; AND METHOD OF TREATING PROLIFERATIVE DISORDERS |
| 04/04/2007 | EP1768678A2 Methods of selectively treating diseases with specific glycosaminoglycan polymers |
| 04/04/2007 | EP1768677A2 Nucleic acids for the treatment of hmgb1-related pathologies |
| 04/04/2007 | EP1768676A1 Use of compounds containing thiol groups as an efflux pump inhibitor |
| 04/04/2007 | EP1768675A1 Combination therapies employing nicotinic acid derivatives or fibric acid derivatives |
| 04/04/2007 | EP1768674A1 Muscarinic antagonists with parp and sir modulating activity as cytoprotective agents |
| 04/04/2007 | EP1768673A1 Orally disintegrating pharmaceutical composition comprising risperidone |
| 04/04/2007 | EP1768672A2 Combination comprising a bcrp inhibitor and 4-(4-methylpiperazin-1-ylmethyl)-n-ý4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl¨-benzamide |
| 04/04/2007 | EP1768671A2 Use of ecteinascidin in the treatment of cancer in patients with low level of brca1 |
| 04/04/2007 | EP1768670A1 Use of flibanserin for the treatment of anorexia nervosa |
| 04/04/2007 | EP1768669A1 Pharmaceutical compositions for the treatment of leishmaniasis |
| 04/04/2007 | EP1768668A2 Multiple ppi dosage form |
| 04/04/2007 | EP1768667A1 Cannabinoid receptor ligands |
| 04/04/2007 | EP1768666A1 Novel uses of porphyrin compounds |
| 04/04/2007 | EP1768665A1 Peptidomimetic inhibitors of retroviral proteases and their use as antivirals |
| 04/04/2007 | EP1768664A1 Combination of dpp-iv inhibitors and compounds modulating 5-ht3 and/or 5-ht4 receptors |
| 04/04/2007 | EP1768663A1 Carbazole-derived pharmaceutical compositions |
| 04/04/2007 | EP1768662A2 Small molecule immunopotentiators and assays for their detection |
| 04/04/2007 | EP1768661A1 Use of targeted oxidative therapeutic formulation in treatment of burns |
| 04/04/2007 | EP1768660A2 Compounds and methods for treating diabetic vascular diseases |
| 04/04/2007 | EP1768659A1 Use of a fatty acid for preparing a topical composition for allaying inflammatory reactions due to venemous hymenoptera stings |
| 04/04/2007 | EP1768658A1 Hydroxyalkylamides |
| 04/04/2007 | EP1768657A1 Methods and compositions for treating ophthalmic conditions with retinyl derivates |
| 04/04/2007 | EP1768656A2 Treatment for ocular disease |
| 04/04/2007 | EP1768655A1 Use of sphingolipids for prevention and treatment of atherosclerosis |
| 04/04/2007 | EP1768654A2 Selective inhibitors of human corticosteroid syntheses |
| 04/04/2007 | EP1768653A2 Methods and compositions for the treatment of attention deficit hyperactivity disorder and hyperphenylalanemia |
| 04/04/2007 | EP1768649A2 Pharmaceutical composition of piperazine derivatives |
| 04/04/2007 | EP1768606A1 A coated medical device and method for making the same |
| 04/04/2007 | EP1768602A2 Combination drug therapy for reducing scar tissue formation |
| 04/04/2007 | EP1768499A1 Medicinal products incorporating bound organosulfur groups |
| 04/04/2007 | EP1696935B1 Novel derivatives of morphine-6-glucuronide, pharmaceutical compositions containing said derivatives, preparation method thereof and uses of same |
| 04/04/2007 | EP1691804B1 Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs |
| 04/04/2007 | EP1663206B1 1-(2,3-dimethyl-phenyl)-ethyl-1,3-dihydro-imidazole-2-thione as non-sedating alpha 2a agonist |
| 04/04/2007 | EP1562932B1 4-tetrazolyl-4-phenylpiperidine derivatives for treating pain |
| 04/04/2007 | EP1556387B1 Substituted benzol e| 1,4| oxazino 3,2-g| isoindole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/04/2007 | EP1551793A4 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 04/04/2007 | EP1549633A4 Nicotine-containing, controlled release composition and method |
| 04/04/2007 | EP1545546B1 Treatment of dyskinesia with 2,3-benzodiazepines |
| 04/04/2007 | EP1545537B1 Alpha-7 nicotinic receptor agonists and statins in combination |
| 04/04/2007 | EP1536797B1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough |
| 04/04/2007 | EP1532135B1 Nf-kb inhibitors |
| 04/04/2007 | EP1487506B1 Preparation for wound healing and prevention of bandage adhesion to the wound |
| 04/04/2007 | EP1472246B1 Oxadiazoles having antiproliferative activity |
| 04/04/2007 | EP1465890B1 Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol |
| 04/04/2007 | EP1427405B1 Inflammation-inhibiting compounds |
| 04/04/2007 | EP1401422B1 Halogenated composition, method for preparing same and uses thereof |
| 04/04/2007 | EP1395254B1 Oral pharmaceutical composition containing a statin derivative |
| 04/04/2007 | EP1383501B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/04/2007 | EP1383447A4 Stent-based delivery of statins to prevent restenosis |
| 04/04/2007 | EP1377556B1 Pyrazole derivatives for treating hiv |
| 04/04/2007 | EP1362033B1 Pyridine matrix metalloproteinase inhibitors |
| 04/04/2007 | EP1352056B1 Polypeptides capable of eliciting an immune reaction against cancer |
| 04/04/2007 | EP1345608B1 Selective dopamine d4 receptor agonists for treating sexual dysfunction |
| 04/04/2007 | EP1332139B1 Anticancer agents based on regulation of protein prenylation |
| 04/04/2007 | EP1331932B1 Use of xestospongin c for treating or preventing hiv infection |
| 04/04/2007 | EP1325757B1 Embolic materials |
| 04/04/2007 | EP1307205B1 Use of 7alpha-hydroxy-estradiol, 7alpha-hydroxy-dehydroepiandrosterone and 7alpha-hydroxy-pregnenolone derivatives for treating acute cellular degeneration |
| 04/04/2007 | EP1239861B1 Combination of cyamemazine and an atypical neuroleptic |
| 04/04/2007 | EP1227721B1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 04/04/2007 | EP1224172B1 Drugs for the treatment of malignant tumours |
| 04/04/2007 | EP1219609B1 Aromatic nitrogenous six-membered ring compounds |
| 04/04/2007 | EP1137420B1 Use of a combination of a purine and a nitrogen monoxide donor for preventing or treating sexual dysfunction |
| 04/04/2007 | EP1117393B1 L-acetylcarnitine as antitumour agent |
| 04/04/2007 | EP1098642B1 Diamino-propanol-compounds for treating ischemia |
| 04/04/2007 | EP1092435B1 Remedies for diabetes |
| 04/04/2007 | EP0980203B1 Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
| 04/04/2007 | EP0969835B1 Use of central cannabinoid receptor antagonists for regulating appetency |
| 04/04/2007 | EP0951292B1 Treating an ischemic disorder and improving stroke outcome |
| 04/04/2007 | CN1942588A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/04/2007 | CN1942479A Thienopyrroles as antagonists of GnRH |
| 04/04/2007 | CN1942475A Substituted thieno - and thiazolo - [2, 3-d] pyridines as inhibitors of Tie2 |
| 04/04/2007 | CN1942473A Process for producing pentacyclic taxane |
| 04/04/2007 | CN1942472A Reverse-turn mimetics and method relating thereto |
| 04/04/2007 | CN1942471A Substituted diaza-spiro-[5.5|-undecane derivatives and their use as neurokinin antagonists |
| 04/04/2007 | CN1942470A Akt活性抑制剂 Akt activity inhibitor |